Atara Biotherapeutics, Inc. - Special Call Transcript

Dec 07, 2020 / 01:30PM GMT
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Atara Biotherapeutics conference call.

(Operator Instructions)

Please be advised that today's conference call is being recorded. I'd now like to hand the conference over to your host today, Mr. Eric Hyllengren, Vice President, Investor Relations and Finance at Atara Biotherapeutics. Please go ahead.

Eric Hyllengren - Atara Biotherapeutics, Inc. - VP of Investor Relations and Finance

Thank you, operator. Good morning everyone, and welcome to Atara's strategic collaboration conference call. On today's call, members from the entire executive team will discuss our recently announced strategic collaboration with Bayer, as well as recent data presented at the ASH Annual Meeting on our CAR T, ATA3219 and tab-cel.

We recently issued a joint press release announcing that Atara and Bayer have entered into a strategic collaboration for mesothelin-targeted CAR T cell therapies for solid tumors as well as a press release on new data on our assets presented at ASH. These press

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot